Stability of nanosuspensions in drug delivery

被引:398
|
作者
Wang, Yancai [1 ,2 ]
Zheng, Ying [2 ]
Zhang, Ling [3 ]
Wang, Qiwei [4 ]
Zhang, Dianrui [4 ]
机构
[1] Shandong Polytech Univ, Sch Chem & Pharmaceut Engn, Jinan 250353, Peoples R China
[2] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Macao, Peoples R China
[3] Shandong Univ Finance & Econ, Jinan 250014, Peoples R China
[4] Shandong Univ, Coll Pharm, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanosuspensions; Stability; Stabilizers; Aggregation; Crystalline transformation; SOLID LIPID NANOPARTICLES; LONG-TERM STABILITY; TOP-DOWN; ANTITUMOR-ACTIVITY; PHARMACOKINETIC EVALUATION; ORIDONIN NANOSUSPENSION; PROCESS PARAMETERS; PARTICLE-SIZE; IN-VITRO; FORMULATION;
D O I
10.1016/j.jconrel.2013.08.006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanosuspensions are nanosized colloidal dispersion systems that are stabilized by surfactants and or polymers. Because nanosizing results in the creation of new interfaces and in a positive Gibbs free energy change, nanosuspensions are thermodynamically unstable systems with a tendency toward agglomeration or crystal growth. Despite extensive research on nanosuspension technology, stability remains a limitation for pharmaceutical or industrial applications of nanosuspensions. Furthermore, the empirical relationship between stabilizer efficacy and nanosuspension stability has not been well characterized. This review focuses on the issue of nanosuspension stability in drug delivery to present the state of the art of nanosuspensions. Therefore, this review will discuss unstable suspensions, methods and guidelines for selecting and optimizing stabilizers, approaches for enhancing stability, and other factors that influence nanosuspension stability. This review could serve as a reference for the educated selection of a stabilizer for a specific drug candidate and the optimization of the operational parameters for inanosuspension formulation, rather than the currently practiced trial-and-error approach. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1126 / 1141
页数:16
相关论文
共 50 条
  • [41] Lentinan as a natural stabilizer with bioactivities for preparation of drug-drug nanosuspensions
    Suo, Zili
    Sun, Qiaomei
    Peng, Xu
    Zhang, Shuangshuang
    Gan, Na
    Zhao, Ludan
    Yuan, Na
    Zhang, Yongkui
    Li, Hui
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 184 : 101 - 108
  • [42] PREPARATION AND EVALUATION OF DRUG-CONTAINING POLYMERIC NANOSUSPENSIONS
    BODMEIER, R
    CHEN, H
    5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : B265 - B268
  • [43] High-Throughput Tools for Optimizing Drug Nanosuspensions
    Leung, Dennis H.
    Rhodes, Timothy
    Bak, Annette
    AMERICAN LABORATORY, 2015, 47 (01) : 12 - +
  • [44] New Approach to Pesticide Delivery Using Nanosuspensions: Research and Applications
    Chin, Chih-Ping
    Wu, Ho-Shing
    Wang, Shaw S.
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2011, 50 (12) : 7637 - 7643
  • [45] Temperature-Induced Surface Effects on Drug Nanosuspensions
    Aleandri, Simone
    Schonenberger, Monica
    Niederquell, Andres
    Kuentz, Martin
    PHARMACEUTICAL RESEARCH, 2018, 35 (03)
  • [46] Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs
    Pu, Xiaohui
    Sun, Jin
    Li, Mo
    He, Zhonggui
    CURRENT NANOSCIENCE, 2009, 5 (04) : 417 - 427
  • [47] Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene
    Rosario Pignatello
    Nadia Ricupero
    Claudio Bucolo
    Francesco Maugeri
    Adriana Maltese
    Giovanni Puglisi
    AAPS PharmSciTech, 7
  • [48] Temperature-Induced Surface Effects on Drug Nanosuspensions
    Simone Aleandri
    Monica Schönenberger
    Andres Niederquell
    Martin Kuentz
    Pharmaceutical Research, 2018, 35
  • [49] Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles
    Yan, Rong
    Xu, Lai
    Wang, Quhe
    Wu, Zheng
    Zhang, Hua
    Gan, Li
    MOLECULAR PHARMACEUTICS, 2021, 18 (12) : 4290 - 4298
  • [50] Ocular tolerability of Eudragit RS100® and RL1009® nanosuspensions as carriers for ophthalmic controlled drug delivery
    Pignatello, R
    Bucolo, C
    Puglisi, G
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (12) : 2636 - 2641